Caris Life Sciences Advances AI for Breast Cancer Care
Irving, Texas, USA, August 7, 2026 Caris Life Sciences has announced the publication of a new study demonstrating that...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Irving, Texas, USA, August 7, 2026 Caris Life Sciences has announced the publication of a new study demonstrating that...
Salt Lake City, Utah, USA, August 7, 2026 Co-Diagnostics, Inc. has reached a major regulatory milestone by submitting a...
BASEL, Switzerland, March 30, 2026 Roche has announced the launch of its cobas® MPX-E assay, a next-generation 4-in-1 multiplex...
